XVIVO

Xermelo MOA 

Prev Next
Previous

Oxidative Damage in Red Blood Cells MOA Animation

Next medical animation of With Alexion Pharmaceuticals, we created a Soliris mechanism of action animation for the treatment of Myasthenia Gravis (MG). MG is an autoimmune disorder characterized by neuromuscular transmission failure and subsequent voluntary muscle weakness.

Soliris MOA Animation

XVIVO partnered with Lexicon Pharmaceuticals to create a series of high end medical animations that provide an overview of carcinoid syndrome diarrhea (CSD). The program illustrates how XERMELO, through the inhibition of TPH, turns down the overproduction of serotonin within neuroendocrine tumor cells, helping patients gain control over carcinoid syndrome.

Keywords: 3D, Video, Patient Education, Cell biology / Histology, Endocrinology / Metabolic, Oncology, Mechanism of Action (MOA)

XVIVO